Efficacy
Initial clinical response in adults
Comparable initial clinical response rate with DIFICID vs vancomycin at end of 10-day treatment
(a) CI (confidence interval) was derived using Wilson score method.
DIFICID®
(fidaxomicin) 200 mg tablets, for oral use
Efficacy
(a) CI (confidence interval) was derived using Wilson score method.
DIFICID is a macrolide antibacterial drug indicated in adult and pediatric patients 6 months of age and older for treatment of Clostridioides difficile-associated diarrhea (CDAD).
To reduce the development of drug-resistant bacteria and maintain the effectiveness of DIFICID and other antibacterial drugs, DIFICID should be used only to treat infections that are proven or strongly suspected to be caused by C. difficile.